
Selling It: Sellas Life Sciences Reveals Exciting Progress in Combination Therapy Trial with Zanubrutinib for DLBCL – SLS009 Shines!
Exciting New Development in Non-Hodgkin Lymphoma Treatment: A Dual Therapy Combination Shines In the ever-evolving world of cancer research, every new discovery brings hope to patients and their families. Recently, a groundbreaking study has revealed impressive results from a clinical trial testing a novel combination therapy for Diffuse Large B-cell Lymphoma (DLBCL), a type of…